Publications by authors named "Mark Velangi"

Claim this Profile
E
Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia.
Angela Rankine-Mullings, Russell Keenan, Subarna Chakravorty, Baba Inusa, Paul Telfer, Mark Velangi

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
Farrukh T Shah, John B Porter, Nandini Sadasivam, Banu Kaya, James C Moon, Mark Velangi

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.
Maria Gabelli, David I Marks, Kirsty Sharplin, Arina Lazareva, Khushnuma Mullanfiroze, Mark Velangi

Br J Haematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine management, healthcare resource use and patient and carer-reported outcomes of patients with transfusion-dependent β-thalassaemia in the United Kingdom: A mixed methods observational study.
Farrukh Shah, Paul Telfer, Mark Velangi, Shivan Pancham, Robert Wynn

EJHaem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
Paul Telfer, Josu De la Fuente, Mamta Sohal, Ralph Brown, Perla Eleftheriou, Mark Velangi

Haematologica· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
Nadia Amin, Sally Kinsey, Richard Feltbower, Jeannette Kraft, Elizabeth Whitehead, Mark Velangi

BMJ Open· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.
Eleni Syrimi, Sanjeeva Gunasekera, Alice Norton, Mark Velangi, Jayashree Motwani

Br J Haematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH.
Ciara O'Rafferty, Mark Velangi, Sarah Lawson, Prashant Hiwarkar, Jayashree Motwani

J Clin Immunol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK experience of unrelated cord blood transplantation in paediatric patients.
Paul Veys, Robert Danby, Ajay Vora, Mary Slatter, Robert Wynn, Mark Velangi

Br J Haematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Carlo Dufour, Paul Veys, Elisa Carraro, Neha Bhatnagar, Marta Pillon, Mark Velangi

Br J Haematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR.
Susanna Akiki, Sara A Dyer, David Grimwade, Adam Ivey, Nervana Abou-Zeid, Mark Velangi

Genes Chromosomes Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia.
Michael Kirwan, Amanda J Walne, Vincent Plagnol, Mark Velangi, Aloysius Ho

Am J Hum Genet· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapy.
Gillian Duthie, Lisa Whyte, Harish Chandran, Sarah Lawson, Mark Velangi

J Pediatr Surg· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemia.
Emmanouil Nikolousis, Mark Velangi

Hematol Rep· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting mismatch repair defects in myeloma.
Mark Velangi, Elizabeth Matheson, Andrew Hall, Julie Irving

Methods Mol Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey.
T C M Morris, Mark Velangi, Graham Jackson, David I Marks, Lisa Ranaghan

Br J Haematol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.
Mark R Velangi, Elizabeth C Matheson, Gareth J Morgan, Graham H Jackson, Penelope R Taylor

Carcinogenesis· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis